Vimarsana
Biggest News Aggregation in the World

Page 2 - Adoptive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adoptive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adoptive Today - Breaking & Trending Today

Adoptive mother who denied wounding child received similar convictions just weeks ago - Vimarsana News

Adoptive mother who denied wounding child received similar convictions just weeks ago

The woman flatly denied beating the girls with wooden rods, a chair and a dog collar.

More Indian firms extending inclusive parental leave to adoptive and LGBTQ+ parents - Vimarsana News

More Indian firms extending inclusive parental leave to adoptive and LGBTQ+ parents

People at Pfizer can also take their three-moth parental leave over a period of two years, as they experience significant changes in life.

'Is my kid alive?': Chinese couple who were given wrong embryo in IVF treatment and raised strangers' son for 10 years awarded US$93,000 compensation from hospital - Vimarsana News

'Is my kid alive?': Chinese couple who were given wrong embryo in IVF treatment and raised strangers' son for 10 years awarded US$93,000 compensation from hospital

A divorced couple in China have won a court case after a hospital IVF blunder left them unknowingly raising another couple’s son for 10 years, but the fate of their embryo remains a mystery.

Source: scmp.com
Video: 60-year-old woman adopted as a baby meets siblings for first time after using 23andMe - Vimarsana News

Video: 60-year-old woman adopted as a baby meets siblings for first time after using 23andMe

"I’m excited for her because now she’s going to be a part of this great big crazy family."

Source: kcra.com
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer - Vimarsana News

Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer

FRAMINGHAM, MA / ACCESSWIRE / August 2, 2022 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard-to-treat